Inolimomab is a mouse monoclonal antibody developed as an immunosuppressive drug against graft-versus-host disease. Its target is the alpha chain of the...
2 KB (137 words) - 06:39, 11 August 2023
Innohep Innopran XL Innovar Inocor inocoterone (INN) inogatran (INN) inolimomab (INN) inolitazone (INN) inotuzumab ozogamicin (INN) Inomax (Ikaria) inosine...
10 KB (484 words) - 21:29, 1 May 2025
Tucotuzumab celmoleukin Antibodies: Basiliximab Daclizumab (dacliximab) Inolimomab IL-3 Agonists: Daniplestim Interleukin 3 Leridistim Milodistim Muplestim...
24 KB (1,920 words) - 21:45, 26 April 2025
Tucotuzumab celmoleukin Antibodies: Basiliximab Daclizumab (dacliximab) Inolimomab IL-3 Agonists: Daniplestim Interleukin 3 Leridistim Milodistim Muplestim...
22 KB (2,685 words) - 12:41, 2 April 2025
Tucotuzumab celmoleukin Antibodies: Basiliximab Daclizumab (dacliximab) Inolimomab IL-3 Agonists: Daniplestim Interleukin 3 Leridistim Milodistim Muplestim...
45 KB (3,810 words) - 19:09, 23 May 2025
Tucotuzumab celmoleukin Antibodies: Basiliximab Daclizumab (dacliximab) Inolimomab IL-3 Agonists: Daniplestim Interleukin 3 Leridistim Milodistim Muplestim...
12 KB (1,289 words) - 19:20, 4 December 2023
Tucotuzumab celmoleukin Antibodies: Basiliximab Daclizumab (dacliximab) Inolimomab IL-3 Agonists: Daniplestim Interleukin 3 Leridistim Milodistim Muplestim...
9 KB (934 words) - 16:50, 3 October 2024
colitis Intetumumab mab human CD51 solid tumors (prostate cancer, melanoma) Inolimomab mab mouse CD25 (α chain of IL-2 receptor) graft versus host disease Inotuzumab...
141 KB (4,321 words) - 00:07, 11 May 2025
Tucotuzumab celmoleukin Antibodies: Basiliximab Daclizumab (dacliximab) Inolimomab IL-3 Agonists: Daniplestim Interleukin 3 Leridistim Milodistim Muplestim...
22 KB (2,581 words) - 20:03, 21 June 2024
Tucotuzumab celmoleukin Antibodies: Basiliximab Daclizumab (dacliximab) Inolimomab IL-3 Agonists: Daniplestim Interleukin 3 Leridistim Milodistim Muplestim...
9 KB (564 words) - 22:09, 25 April 2025
Tucotuzumab celmoleukin Antibodies: Basiliximab Daclizumab (dacliximab) Inolimomab IL-3 Agonists: Daniplestim Interleukin 3 Leridistim Milodistim Muplestim...
26 KB (3,273 words) - 08:48, 14 October 2024
Tucotuzumab celmoleukin Antibodies: Basiliximab Daclizumab (dacliximab) Inolimomab IL-3 Agonists: Daniplestim Interleukin 3 Leridistim Milodistim Muplestim...
43 KB (3,445 words) - 20:45, 28 March 2025
Tucotuzumab celmoleukin Antibodies: Basiliximab Daclizumab (dacliximab) Inolimomab IL-3 Agonists: Daniplestim Interleukin 3 Leridistim Milodistim Muplestim...
16 KB (1,245 words) - 07:59, 10 January 2025
Tucotuzumab celmoleukin Antibodies: Basiliximab Daclizumab (dacliximab) Inolimomab IL-3 Agonists: Daniplestim Interleukin 3 Leridistim Milodistim Muplestim...
21 KB (2,127 words) - 05:10, 21 January 2025
Nivolumab/relatlimab Mouse Afelimomab Elsilimomab Faralimomab Gavilimomab Inolimomab Maslimomab Nerelimomab Odulimomab Telimomab aritox Vepalimomab Zolimomab...
38 KB (4,316 words) - 01:22, 4 February 2025
Tucotuzumab celmoleukin Antibodies: Basiliximab Daclizumab (dacliximab) Inolimomab IL-3 Agonists: Daniplestim Interleukin 3 Leridistim Milodistim Muplestim...
14 KB (1,578 words) - 15:30, 24 January 2025
Tucotuzumab celmoleukin Antibodies: Basiliximab Daclizumab (dacliximab) Inolimomab IL-3 Agonists: Daniplestim Interleukin 3 Leridistim Milodistim Muplestim...
15 KB (1,060 words) - 15:06, 20 May 2025
Tucotuzumab celmoleukin Antibodies: Basiliximab Daclizumab (dacliximab) Inolimomab IL-3 Agonists: Daniplestim Interleukin 3 Leridistim Milodistim Muplestim...
16 KB (1,451 words) - 18:24, 2 August 2024
Tucotuzumab celmoleukin Antibodies: Basiliximab Daclizumab (dacliximab) Inolimomab IL-3 Agonists: Daniplestim Interleukin 3 Leridistim Milodistim Muplestim...
25 KB (2,148 words) - 22:52, 25 April 2025
Tucotuzumab celmoleukin Antibodies: Basiliximab Daclizumab (dacliximab) Inolimomab IL-3 Agonists: Daniplestim Interleukin 3 Leridistim Milodistim Muplestim...
43 KB (5,007 words) - 10:38, 22 December 2024
Tucotuzumab celmoleukin Antibodies: Basiliximab Daclizumab (dacliximab) Inolimomab IL-3 Agonists: Daniplestim Interleukin 3 Leridistim Milodistim Muplestim...
15 KB (1,294 words) - 22:06, 7 March 2025
Tucotuzumab celmoleukin Antibodies: Basiliximab Daclizumab (dacliximab) Inolimomab IL-3 Agonists: Daniplestim Interleukin 3 Leridistim Milodistim Muplestim...
13 KB (946 words) - 05:32, 11 February 2025
Tucotuzumab celmoleukin Antibodies: Basiliximab Daclizumab (dacliximab) Inolimomab IL-3 Agonists: Daniplestim Interleukin 3 Leridistim Milodistim Muplestim...
14 KB (1,147 words) - 12:50, 2 May 2025
Tucotuzumab celmoleukin Antibodies: Basiliximab Daclizumab (dacliximab) Inolimomab IL-3 Agonists: Daniplestim Interleukin 3 Leridistim Milodistim Muplestim...
50 KB (6,093 words) - 20:45, 19 November 2024
Tucotuzumab celmoleukin Antibodies: Basiliximab Daclizumab (dacliximab) Inolimomab IL-3 Agonists: Daniplestim Interleukin 3 Leridistim Milodistim Muplestim...
7 KB (412 words) - 13:44, 11 March 2025
Tucotuzumab celmoleukin Antibodies: Basiliximab Daclizumab (dacliximab) Inolimomab IL-3 Agonists: Daniplestim Interleukin 3 Leridistim Milodistim Muplestim...
25 KB (3,036 words) - 18:36, 23 May 2025
Tucotuzumab celmoleukin Antibodies: Basiliximab Daclizumab (dacliximab) Inolimomab IL-3 Agonists: Daniplestim Interleukin 3 Leridistim Milodistim Muplestim...
16 KB (1,943 words) - 13:51, 29 December 2024
Tucotuzumab celmoleukin Antibodies: Basiliximab Daclizumab (dacliximab) Inolimomab IL-3 Agonists: Daniplestim Interleukin 3 Leridistim Milodistim Muplestim...
13 KB (1,487 words) - 10:31, 10 January 2024
Tucotuzumab celmoleukin Antibodies: Basiliximab Daclizumab (dacliximab) Inolimomab IL-3 Agonists: Daniplestim Interleukin 3 Leridistim Milodistim Muplestim...
3 KB (244 words) - 17:53, 24 January 2023
Tucotuzumab celmoleukin Antibodies: Basiliximab Daclizumab (dacliximab) Inolimomab IL-3 Agonists: Daniplestim Interleukin 3 Leridistim Milodistim Muplestim...
18 KB (1,659 words) - 22:53, 25 April 2025